Source: ERJ Open Res, 7 (3) 00178-2021; 10.1183/23120541.00178-2021
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Chintal H. Shah, Robert M. Reed, Yulan Liang, Zafar Zafari. Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality. ERJ Open Res, 7 (3) 00178-2021; 10.1183/23120541.00178-2021

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 Myocardial infarction, heart failure and mortality in patients with COPD in primary care. Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD Source: Eur Respir J 2010; 35: 1003-1021 Year: 2010 COPD coronary/peripheral vascular disease Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Exacerbation frequency and increased risk of myocardial infarction in COPD Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 Systemic manifestations and comorbidities of COPD Source: Eur Respir J 2009; 33: 1165-1185 Year: 2009 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019 No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019 Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 High coincidence of COPD with increased mortality in an unselected group of Danish patients with acute myocardial infarction Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005 COPD-related morbidity and mortality after smoking cessation: status of the evidence Source: Eur Respir J 2008; 32: 844-853 Year: 2008 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 Effect of severity of exacerbations of COPD and hospitalised pneumonia on risk of myocardial infarction Source: International Congress 2017 – COPD: risk factors and prognosis Year: 2017 Associations between arterial calcification and stiffness, bone density, emphysema and all-cause mortality in COPD patients Source: Annual Congress 2013 –The best posters in chronic care Year: 2013